alpha-DihydroartemisininCAS# 81496-81-3 |
- Dihydroartemisinin
Catalog No.:BCN6264
CAS No.:71939-50-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 81496-81-3 | SDF | Download SDF |
| PubChem ID | 179336 | Appearance | Cryst. |
| Formula | C15H24O5 | M.Wt | 284.34 |
| Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)O)C | ||
| Standard InChIKey | BJDCWCLMFKKGEE-FTRRWEDQSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Dihydroartemisinin is widely used as an intermediate in the preparation of other artemisinin-derived antimalarial drugs, is recommended as the first-line anti-malarial drug with low toxicity. Dihydroartemisinin possesses promising anticancer activities and induce cancer cell death through apoptotic pathways. |
| Targets | Antifection |
| Structure Identification | J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Nov 1;875(1):180-91.On-column epimerization of dihydroartemisinin: an effective analytical approach to overcome the shortcomings of the International Pharmacopoeia monograph.[Pubmed: 18617445]We developed a cryo-HPLC/UV method for the simultaneous determination of artemisinin (1), alpha-Dihydroartemisinin (2alpha), beta-dihydroartemisinin (2beta), and a ubiquitous thermal decomposition product of 2 (designated as diketoaldehyde, 3), starting from the International Pharmacopoeia monograph on dihydroartemisinin. The method takes for the first time the on-column epimerization process of 2 into consideration. Chromatographic separation was obtained under reversed-phase conditions on a Symmetry C18 column (3.5 microm particle size) with a mobile phase consisting of acetonitrile-water 60:40 (v/v), delivered at 0.60-1.00 ml/min flow-rates, with ultraviolet detection at low wavelength (lambda = 210 nm). |
alpha-Dihydroartemisinin Dilution Calculator
alpha-Dihydroartemisinin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.5169 mL | 17.5846 mL | 35.1692 mL | 70.3383 mL | 87.9229 mL |
| 5 mM | 0.7034 mL | 3.5169 mL | 7.0338 mL | 14.0677 mL | 17.5846 mL |
| 10 mM | 0.3517 mL | 1.7585 mL | 3.5169 mL | 7.0338 mL | 8.7923 mL |
| 50 mM | 0.0703 mL | 0.3517 mL | 0.7034 mL | 1.4068 mL | 1.7585 mL |
| 100 mM | 0.0352 mL | 0.1758 mL | 0.3517 mL | 0.7034 mL | 0.8792 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 1-Hydroxypinoresinol 1-O-glucoside
Catalog No.:BCN7019
CAS No.:81495-71-8
- Taxagifine
Catalog No.:BCN6949
CAS No.:81489-69-2
- (-)-Pinoresinol
Catalog No.:BCN3254
CAS No.:81446-29-9
- 8-Hydroxypinoresinol
Catalog No.:BCN3389
CAS No.:81426-17-7
- 8-Acetoxypinoresinol
Catalog No.:BCN2161
CAS No.:81426-14-4
- Sanggenone D
Catalog No.:BCN1194
CAS No.:81422-93-7
- Cabergoline
Catalog No.:BCC5276
CAS No.:81409-90-7
- EHNA hydrochloride
Catalog No.:BCC6996
CAS No.:81408-49-3
- Alfuzosin
Catalog No.:BCC4080
CAS No.:81403-80-7
- Alfuzosin HCl
Catalog No.:BCC2494
CAS No.:81403-68-1
- Acetylvalerenolic acid
Catalog No.:BCC8112
CAS No.:81397-67-3
- Fmoc-His(Boc)-OH.CHA
Catalog No.:BCC2595
CAS No.:81379-52-4
- Nafamostat
Catalog No.:BCC4187
CAS No.:81525-10-2
- Forsythoside B
Catalog No.:BCN1205
CAS No.:81525-13-5
- 2-Pentadecenedioic acid
Catalog No.:BCN3666
CAS No.:81588-35-4
- Neuromedin C (porcine)
Catalog No.:BCC5832
CAS No.:81608-30-2
- Withaperuvin C
Catalog No.:BCN6727
CAS No.:81644-34-0
- Canusesnol A
Catalog No.:BCN4350
CAS No.:816456-90-3
- 3-Dehydro-15-deoxoeucosterol
Catalog No.:BCN4351
CAS No.:81678-46-8
- 18-Beta-hydroxy-3-epi-alpha-yohimbine
Catalog No.:BCN3518
CAS No.:81703-06-2
- Rehmannioside A
Catalog No.:BCN2885
CAS No.:81720-05-0
- Rehmannioside B
Catalog No.:BCN8468
CAS No.:81720-06-1
- Rehmannioside C
Catalog No.:BCN8183
CAS No.:81720-07-2
- Rhmannioside D
Catalog No.:BCN2362
CAS No.:81720-08-3
On-column epimerization of dihydroartemisinin: an effective analytical approach to overcome the shortcomings of the International Pharmacopoeia monograph.[Pubmed:18617445]
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Nov 1;875(1):180-91.
We developed a cryo-HPLC/UV method for the simultaneous determination of artemisinin (1), alpha-Dihydroartemisinin (2alpha), beta-dihydroartemisinin (2beta), and a ubiquitous thermal decomposition product of 2 (designated as diketoaldehyde, 3), starting from the International Pharmacopoeia monograph on dihydroartemisinin. The method takes for the first time the on-column epimerization process of 2 into consideration. Chromatographic separation was obtained under reversed-phase conditions on a Symmetry C18 column (3.5 microm particle size) with a mobile phase consisting of acetonitrile-water 60:40 (v/v), delivered at 0.60-1.00 ml/min flow-rates, with ultraviolet detection at low wavelength (lambda = 210 nm). Low temperatures (T = 0-10 degrees C) were selected on the grounds of a diastereoselective dynamic HPLC (DHPLC) study performed at different temperatures, aimed at identifying the best experimental conditions capable of minimizing the on-column interconversion process.
